Published in Lancet on March 15, 2003
Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding (Early TIPSS) | NCT02377141
Liver cirrhosis. Lancet (2008) 6.11
Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology (2010) 2.68
The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol (2009) 1.69
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg (2005) 1.21
Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ (2006) 1.10
Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol (2014) 1.00
Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Endoscopic management of esophagogastric varices in Japan. Ann Transl Med (2014) 0.91
Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol (2014) 0.87
Pathophysiology of portal hypertension and esophageal varices. Int J Hepatol (2012) 0.87
Duplex Doppler ultrasound examination of the portal venous system: an emerging novel technique for the estimation of portal vein pressure. Dig Dis Sci (2009) 0.86
Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine prehepatic portal hypertension. Am J Physiol Gastrointest Liver Physiol (2008) 0.86
Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage. Int J Hepatol (2011) 0.84
Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol (2014) 0.84
Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol (2011) 0.84
Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr (2011) 0.84
Transjugular intrahepatic portosystemic shunt. Clin Liver Dis (2014) 0.84
Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement. World J Hepatol (2015) 0.82
Update of endoscopy in liver disease: more than just treating varices. World J Gastroenterol (2012) 0.81
Detection of esophageal varices using CT and MRI. Dig Dis Sci (2011) 0.81
Endoscopic management of esophageal varices. World J Gastrointest Endosc (2012) 0.81
The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis. Patient Prefer Adherence (2015) 0.80
Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance. Ther Adv Chronic Dis (2013) 0.80
Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding. World J Gastroenterol (2013) 0.80
Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices. PLoS One (2013) 0.79
Follow-up study of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension. Dig Dis Sci (2011) 0.78
Prevention and management of gastroesophageal varices in cirrhosis. Int J Hepatol (2012) 0.78
Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding. World J Gastroenterol (2012) 0.77
Risk factors for early rebleeding and mortality in acute variceal hemorrhage. World J Gastroenterol (2014) 0.77
Prevention of variceal rebleeding. Lancet (2003) 0.77
Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open (2013) 0.76
The treatment of hepatic encephalopathy in the cirrhotic patient. Gastroenterol Hepatol (N Y) (2010) 0.76
Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis. BMJ Open (2016) 0.76
Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension. Exp Ther Med (2016) 0.75
Selective Intestinal Decontamination in Portal Hypertension. Gastroenterol Hepatol (N Y) (2006) 0.75
Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding. Clin Mol Hepatol (2016) 0.75
Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis. Int J Clin Exp Med (2015) 0.75
Partial splenic embolization for gastroesophageal variceal bleeding: A potential long waiting to be tapped. Saudi J Gastroenterol (2016) 0.75
Portal hypertension--old problem, new therapeutic solutions. Wien Med Wochenschr (2006) 0.75
A subacute epidural haematoma extending over the occipital region and posterior cranial fossa due to a laceration in the transverse sinus. Int J Legal Med (2011) 0.75
Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. Hepatology (2017) 0.75
Stent Placement for Portal Vein Stenosis After Pancreaticoduodenectomy. World J Surg (2015) 0.75
Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol (2012) 4.62
Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology (2012) 3.86
Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology (2010) 2.39
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology (2002) 2.12
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology (2006) 2.03
Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension. Gut (2011) 1.66
Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol (2009) 1.57
Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology (2010) 1.53
Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut (2012) 1.51
Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin. J Hepatol (2007) 1.51
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology (2009) 1.49
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins. J Hepatol (2012) 1.48
Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol (2010) 1.37
Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology (2002) 1.30
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology (2013) 1.23
Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. PLoS One (2012) 1.13
Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. J Hepatol (2007) 1.04
Portal cholangiopathy: radiological classification and natural history. Gut (2011) 1.04
TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology (2002) 1.01
Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension. J Clin Gastroenterol (2005) 0.99
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology (2004) 0.98
Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction. Hepatology (2013) 0.94
Sonography of Budd-Chiari syndrome. AJR Am J Roentgenol (2006) 0.94
Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol (2008) 0.93
Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology (2006) 0.93
Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig Liver Dis (2012) 0.93
Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome. AJR Am J Roentgenol (2003) 0.90
Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension. Diagn Microbiol Infect Dis (2004) 0.89
Nitric oxide and portal hypertension. Metab Brain Dis (2002) 0.88
Utility of color Doppler ultrasonography predicting tips dysfunction. Am J Gastroenterol (2005) 0.87
Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers. Hepatology (2012) 0.82
Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial. Am J Clin Nutr (2012) 0.82
Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension. J Hepatol (2013) 0.81
Insulin resistance in patients with cirrhosis and portal hypertension. Am J Physiol Gastrointest Liver Physiol (2012) 0.81
Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis. Hepatology (2006) 0.81
Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats. Hepatology (2013) 0.80
Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol (2013) 0.79
Patients whose first episode of bleeding occurs while taking a β-blocker have high long-term risks of rebleeding and death. Clin Gastroenterol Hepatol (2012) 0.78
Increased CD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera. Br J Haematol (2004) 0.78
Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis. Clin Gastroenterol Hepatol (2011) 0.77
Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis. Am J Physiol Gastrointest Liver Physiol (2013) 0.76
Stroke volume response to liver graft reperfusion stress in cirrhotic patients. World J Surg (2014) 0.76
Lack of correlation between preoperative and intraoperative liver hemodynamics: a descriptive analysis. Transplantation (2014) 0.76
Reply: To PMID 23058320. Gastroenterology (2013) 0.75
ACP Journal Club. Early use of TIPS in patients with cirrhosis and variceal bleeding. Ann Intern Med (2010) 0.75
Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route. Transplantation (2006) 0.75
[Portal vein thrombosis]. Rev Esp Enferm Dig (2012) 0.75
[Portal vein thrombosis]. Gastroenterol Hepatol (2009) 0.75
Simvastatin Attenuates Liver Injury in Rodents with Biliary Cirrhosis Submitted to Hemorrhage/Resuscitation. Shock (2017) 0.75
[Diagnosis and treatment of portal thrombosis in liver cirrhosis]. Gastroenterol Hepatol (2012) 0.75
[Portal hypertension: recommendations for evaluation and treatment: consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases(CIBERehd)]. Gastroenterol Hepatol (2012) 0.75